TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
RDY

Dr. Reddy’s Laboratories Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

12.50$ +2.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement RDY
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
42.4% 40.4% 44.4% 46.3% 45.8% 46.2% 49.2% 46.9% 43.3% 41.4% 41.5% 47.2%
57.6% 59.6% 55.6% 53.7% 54.2% 53.8% 50.8% 53.1% 56.7% 58.6% 58.5% 52.8%
11.8% 11.5% 13.9% 12.9% 10.1% 8.8% 8.2% 8.2% 7.9% 8.2% 8.4% 7.2%
0.5% 0.4% 0.5% 0.5% 0.5% 28.7% 2,134.8% 29.0% 18.9% 27.7% 28.8% 16.9%
39.9% 40.5% 46.1% 45.3% 40.7% 44.7% 33.9% 39.4% 33.4% 34.3% 36.4% 38.9%
17.7% 19.1% 9.6% 8.4% 13.6% 9.2% 16.9% 13.7% 23.2% 24.3% 22.1% 13.8%
0.7% 0.5% 0.5% 0.6% 0.6% 0.0% 38.0% 0.4% 0.6% 0.6% 0.9% 1.1%
19.0% 17.5% 10.4% 10.1% 14.6% 10.3% 13.9% 15.1% 24.6% 25.7% 23.6% 16.3%
4.0% 4.6% 1.9% 3.2% 2.4% -0.8% 4.8% 4.1% 6.2% 5.8% 6.0% 3.7%
15.0% 12.9% 8.5% 6.9% 12.2% 11.2% 9.1% 11.0% 18.3% 19.9% 17.4% 12.8%
23.2% 25.8% 17.6% 16.6% 23.1% 23.9% 20.9% 21.0% 30.3% 31.7% 29.7% 23.6%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?